Related Experiment Video
Updated: Aug 17, 2026

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
Published on: April 28, 2014
Management of infections due to antibiotic-resistant Streptococcus pneumoniae
1Section of Pediatric Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030, USA. skaplan@bcm.tmc.edu
Abstract:
Antibiotic-resistant strains of Streptococcus pneumoniae are becoming more prevalent throughout the world; this has resulted in modifications of treatment approaches. Management of bacterial meningitis has the greatest consensus. Strategies for treating other systemic infections such as pneumonia, bacteremia, and musculoskeletal infections are evolving, in part related to the availability of new antibiotics which are active in vitro against isolates resistant to penicillin and the extended-spectrum cephalosporins. However, there are currently very limited data related to the clinical efficacy of these new agents. The studies upon which current recommendations are based are reviewed. Otitis media represents the single most common infection due to S. pneumoniae. Recommendations for treatment of acute otitis media due to drug-resistant strains and the rationale for these recommendations are discussed.
Insights
Antibiotic resistance in Streptococcus pneumoniae is increasing globally, necessitating updated treatment strategies. This review examines current recommendations for managing S. pneumoniae infections, particularly acute otitis media, focusing on emerging drug-resistant strains.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Increasing global prevalence of antibiotic-resistant Streptococcus pneumoniae strains.
- Need for evolving treatment strategies for systemic S. pneumoniae infections like pneumonia and bacteremia.
- Limited clinical efficacy data for new antibiotics against resistant S. pneumoniae isolates.
Purpose of the Study:
- To review studies informing current treatment recommendations for S. pneumoniae infections.
- To discuss evolving strategies for systemic infections.
- To provide recommendations for treating acute otitis media caused by drug-resistant S. pneumoniae.
Main Methods:
- Review of existing studies and clinical data.
- Analysis of treatment guidelines for bacterial meningitis.
- Evaluation of recommendations for pneumonia, bacteremia, and musculoskeletal infections.
- Focus on otitis media treatment strategies.
Main Results:
- Bacterial meningitis management shows consensus.
- Treatment strategies for other infections are evolving due to new antibiotics.
- Clinical efficacy data for new agents against resistant S. pneumoniae are limited.
- Otitis media is the most common S. pneumoniae infection.
Conclusions:
- Current recommendations for S. pneumoniae infections are based on reviewed studies.
- New antibiotics show in vitro activity but limited clinical data exist.
- Specific recommendations for acute otitis media due to drug-resistant S. pneumoniae are discussed.
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Acute Pyelonephritis II: Diagnostic Studies and Management
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Pneumonia I: Introduction

